AcelRx Pharma Balance Sheet - Quarterly (NASDAQ:ACRX)

Add to My Stocks
$3.45 $0.05 (1.47%) ACRX stock closing price Sep 17, 2018 (Closing)

A thorough fundamental analysis involves using data from AcelRx Pharma balance sheet, apart from other financial statements, to value the business. How cash on hand has increased or decreased is one of the many indicators used while undertaking the AcelRx Pharma stock analysis, and provides insights into the firm's financial performance. Quarterly results announcements include the release of all three financial statements, of which the balance sheet is one. AcelRx Pharma had a long term debt of $7.54M at the end of 2018 Q2. To understand the debt servicing capacity of the company, one needs to look at AcelRx Pharma operating cash flow and AcelRx Pharma revenue also. AcelRx Pharma debt to equity ratio is -.

View and download AcelRx Pharma quarterly results to get the balance sheet details for the latest 40 quarters data.
show more
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q1
Marketable Securities16.85M7.57M7.56M-----1M1.72M
Raw Materials----------
Work In Progress----------
Finished Goods----------
Notes Receivable----------
Other Current Assets1.05M1.04M---1.07M-1.06M1.23M1.52M
Total Current Assets
Property Plant & Equipment--19.48M---17.44M---
Accumulated Depreciation--8.43M---6.73M---
Net Property Plant & Equipment
Investment & Advances----------
Other Non-Current Assets----------
Deferred Charges----------
Deposits & Other Assets----------
Total Assets
Notes Payable----------
Accounts Payable1.8M2.3M1.42M1.24M1.02M1.68M1.55M1.35M2.85M3.6M
Current Portion Long-Term Debt8.14M7.92M7.72M9.25M7.12M5.05M2.91M9.18M13.94M9.19M
Current Portion Capital Leases----------
Accrued Expenses2.55M2.21M3.54M3.53M4.36M4.54M4.59M4.14M2.91M2.44M
Income Taxes Payable----------
Other Current Liabilities----1.03M1.46M1.12M-1.31M1.57M
Total Current Liabilities
Deferred Taxes/Income3.77M3.87M3.84M3.82M3.64M3.73M3.86M4.01M3.11M2.63M
Convertible Debt----------
Long-Term Debt7.54M9.49M11.36M13.15M14.89M16.58M18.63M12.14M7.4M11.94M
Non-Current Capital Leases----------
Other Long-Term Liabilities89.06M86.06M83.19M81.2M77.71M75.02M72.63M71.04M68.52M66.39M
Total Liabilities
Minority Interest----------
Preferred Stock----------
Common Stock Net----------
Capital Surplus270.98M262.53M261.31M257.62M243.3M242.21M240.97M239.9M238.72M237.58M
Retained Earnings-320M-309.46M-297.87M-287.98M-274.97M-261.91M-246.36M-236.68M-225.27M-214.18M
Treasury Stock----------
Other Liabilities----------
Shareholders Equity-48.97M-46.88M-36.5M-30.3M-31.62M-19.65M-5.33M3.27M13.49M23.44M
Total Liabilities & Shareholders Equity64.62M65.81M75.55M82.74M78.19M88.44M99.99M105.99M113.57M121.22M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Most investors just check the AcelRx Pharma stock price, and AcelRx Pharma historical stock prices before investing. While share price is an important factor, one should also look at financials and valuation metrics like the AcelRx Pharma PE ratio chart. Below is a brief explanation of common balance sheet terms:

  • Assets: Anything that the AcelRx Pharma company owns and is a part of its books. Assets can be of three types: fixed, current and other assets which includes intangibles, advances. Internet companies typically don't have a lot of assets as there is not much investment in say machinery, equipment etc. AcelRx Pharma had total assets of $64.62M.
  • Liabilities include short term loans and long term loans availed by the company to fund its business operations. ACRX stock had total liabilities of $113.59M for the quarter 2018 Q2.

AcelRx Pharma Balance Sheet - Key Ratios

Current ratio
Debt to equity ratio
Asset turnover ratio
Receivables turnover